Synthesis and preliminary evaluation of Tc-99m-labeled somatostatin analog (RC-160) using “3 + 1” mixed ligand approach

Nuclear Medicine and Biology

Volumn 28, Issue 3, 2001, Pages 225-233

  Amartey, J K ^a   Parhar, R S ^a   Al Jammaz, I ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

Cancer detection; Mixed ligand complex; Somatostatin analog; Technetium 99m

Indexed keywords

CYSTEINE; DIAGNOSTIC AGENT; LIGAND; PERTECHNETIC ACID TC 99M; RHENIUM; SOMATOSTATIN DERIVATIVE; UNCLASSIFIED DRUG; VAPREOTIDE; VAPREOTIDE TC 99M;

ANIMAL EXPERIMENT; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER DIAGNOSIS; CHROMATOGRAPHY; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; DRUG TISSUE LEVEL; HUMAN; HUMAN CELL; IMAGING; ISOTOPE LABELING; LIGAND BINDING; MOUSE; NONHUMAN; TARGET CELL; TISSUE DISTRIBUTION;

ANIMALS; BREAST NEOPLASMS; FEMALE; HUMANS; LIGANDS; MICE; RADIOLIGAND ASSAY; RADIOPHARMACEUTICALS; SOMATOSTATIN; TECHNETIUM COMPOUNDS; TISSUE DISTRIBUTION; TUMOR CELLS, CULTURED;

EID: 0035059242     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(00)00183-9     Document Type: Article

References (27)

1. Distribution of somatostatin receptors in normal and tumor tissue
2. Binding properties of somatostatin receptor subtypes
3. Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hsstr1-5)
4. Cloned somatostatin receptors: Identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides
5. Insulin secretion is inhibited by subtype five somatostatin in the mouse
6. Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: Quantitative double-label immunohistochemical analysis
7. Colocalization of somatostatin receptor sst5 and insulin in rat pancreatic beta cells
8. Somatostatin inhibits β-cell secretion via a subtype-2 somatostatin receptor in the isolated perfused human pancreas
9. Immunohistochemical localization of somatostatin receptor sst2A in human pancreatic islets
10. Receptor scintigraphy with a radioiodinated somatostatin analogue: Radiolabelling, purification, biologic activity, and in vivo application in animals
11. Somatostatin receptor scintigraphy with [In-111-DTPA-D-Phe] and [I-123-Tyr-3] octreotide: The Rotterdam experience with more than 1000 patients
12. Synthesis and biological evaluation of Tc-99m-cyclopentadienyltricarbonyltechnetium-labeled octreotide
13. 3 as prosthetic groups for labeling amines and peptides: Approaches with pre- and post-conjugation labeling
14. New octreotide derivatives labeled with technetium-99m
15. Design, synthesis, and initial evaluation of high-affinity technetium bombesin analogues
16. Preclinical evaluation of technetium-99m-labeled somatostatin receptor-binding peptides
17. Radiolabeled somatostatin analogs in prostate cancer
18. Synthesis and characterization of oxotechnetium (V) mixed-ligand complexes containing a tridentate N-substituted bis (mercaptoethyl) amine and a monodentate thiol
19. 99mTc complexes
20. Characterization and preliminary evaluation of ester-modified technetium-99m SNS/S mixed ligand complexes as potential brain perfusion agents
21. 6
22. 2 complexes as myocardial perfusion imaging agents
23. New bisaminoethanethiol (BAT) ligands which form two interconvertible Tc-99m complexes
24. Addition of sulfhydryl groups to Escherichia coli ribosomes by protein modification with 2-iminothiolane
25. 99mTc complexation reactions
26. Somatostatin receptors on two human cancer cell lines: Clinical implications in nuclear medicine
27. Technetium-99m labeled somatostatin and analogs: Synthesis, characterization and in vivo evaluation